Marinova is thrilled to introduce our newest team member to our readers, Dr Ahyoung Park. Dr Park has an extensive background in biology, analytical and inorganic chemistry and professional experience across five countries.

Adding to the existing evidence supporting the anti-tumorigenic properties of fucoidan, a new colorectal cancer clinical study has found that orally-ingested fucoidan significantly improved patients’ disease control rate by 24%.